Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial

Casper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen, Lars Kristian Munck, Jan Fallingborg, Lisbet Ambrosius Christensen, Gitte Pedersen, Jens Kjeldsen, Bent Ascanius Jacobsen, Anne Sophie Oxholm, Jakob Kjellberg, Klaus Bendtzen, Mark Andrew Ainsworth

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

257 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftGut
Vol/bind63
Udgave nummer6
Sider (fra-til)919-927
ISSN0017-5749
DOI
StatusUdgivet - 2014

Fingerprint

Crohn Disease
Randomized Controlled Trials
Costs and Cost Analysis
Therapeutics
Health Care Costs
Infliximab
Single-Blind Method
Health Care Sector
Antibodies
Multicenter Studies
Fistula
Cost-Benefit Analysis
Registries
Hospitalization
Outpatients
Serum

Citer dette

Steenholdt, Casper ; Brynskov, Jørn ; Thomsen, Ole Østergaard ; Munck, Lars Kristian ; Fallingborg, Jan ; Christensen, Lisbet Ambrosius ; Pedersen, Gitte ; Kjeldsen, Jens ; Jacobsen, Bent Ascanius ; Oxholm, Anne Sophie ; Kjellberg, Jakob ; Bendtzen, Klaus ; Ainsworth, Mark Andrew. / Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment : a randomised, controlled trial. I: Gut. 2014 ; Bind 63, Nr. 6. s. 919-927.
@article{35bcd53bb09a477d88c788eb02b15a38,
title = "Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial",
author = "Casper Steenholdt and J{\o}rn Brynskov and Thomsen, {Ole {\O}stergaard} and Munck, {Lars Kristian} and Jan Fallingborg and Christensen, {Lisbet Ambrosius} and Gitte Pedersen and Jens Kjeldsen and Jacobsen, {Bent Ascanius} and Oxholm, {Anne Sophie} and Jakob Kjellberg and Klaus Bendtzen and Ainsworth, {Mark Andrew}",
year = "2014",
doi = "10.1136/gutjnl-2013-305279",
language = "English",
volume = "63",
pages = "919--927",
journal = "Gut",
issn = "0017-5749",
publisher = "B M J Group",
number = "6",

}

Steenholdt, C, Brynskov, J, Thomsen, OØ, Munck, LK, Fallingborg, J, Christensen, LA, Pedersen, G, Kjeldsen, J, Jacobsen, BA, Oxholm, AS, Kjellberg, J, Bendtzen, K & Ainsworth, MA 2014, 'Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial', Gut, bind 63, nr. 6, s. 919-927. https://doi.org/10.1136/gutjnl-2013-305279

Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment : a randomised, controlled trial. / Steenholdt, Casper; Brynskov, Jørn; Thomsen, Ole Østergaard; Munck, Lars Kristian; Fallingborg, Jan; Christensen, Lisbet Ambrosius; Pedersen, Gitte; Kjeldsen, Jens; Jacobsen, Bent Ascanius; Oxholm, Anne Sophie; Kjellberg, Jakob; Bendtzen, Klaus; Ainsworth, Mark Andrew.

I: Gut, Bind 63, Nr. 6, 2014, s. 919-927.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment

T2 - a randomised, controlled trial

AU - Steenholdt, Casper

AU - Brynskov, Jørn

AU - Thomsen, Ole Østergaard

AU - Munck, Lars Kristian

AU - Fallingborg, Jan

AU - Christensen, Lisbet Ambrosius

AU - Pedersen, Gitte

AU - Kjeldsen, Jens

AU - Jacobsen, Bent Ascanius

AU - Oxholm, Anne Sophie

AU - Kjellberg, Jakob

AU - Bendtzen, Klaus

AU - Ainsworth, Mark Andrew

PY - 2014

Y1 - 2014

U2 - 10.1136/gutjnl-2013-305279

DO - 10.1136/gutjnl-2013-305279

M3 - Journal article

C2 - 23878167

VL - 63

SP - 919

EP - 927

JO - Gut

JF - Gut

SN - 0017-5749

IS - 6

ER -